Clinical Trials Browser

Completed × Carcinoma, Basal Cell × pembrolizumab × Clear all

NCT02690948 2019-03-08

Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer

Phase 1/2 Completed

16 enrolled 15 charts

Carcinoma, Basal Cell